4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that its management will present and host one-on-one meetings at the virtual BTIG Digital Health Forum on November 25, 2024. Presentations at the event will include: 9:00 am ET Fireside Chat: Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will discuss Butterfly's differentiated technology, strategic approach, and future opportunities. 3:00 pm ET Panel Discussion: John Martin, MD, Chief Medical Officer, will discuss t

Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Butterfly iQ3™, its third-generation handheld ultrasound device, was the recipient of the Best Medical Technology Award at the 2024 Prix Galien USA Awards by the Galien Foundation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108425693/en/Butterfly Network's Chief Executive Officer, Joseph DeVivo; Co-Founder & VP of Core Technology, Nevada Sanchez; and Chief Strategy Officer, Darius Shahida, accept the Prix Galien US

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation at the Canaccord Genuity (CG) MedTech, Diagnostics and Digital Health & Services Forum in New York City on November 21, 2024. Joseph DeVivo, President, Chief Executive Officer & Chairman, and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings throughout the day, and Mr. DeVivo will deliver a business overview presentation at 11:00 am ET. A webcast of the presentation will be posted to the Events & Presentations section of the Butterfly investor w

Delivered Quarterly Revenue of $20.6mm, 33% YoY Growth Raises Full Year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $20.6 million in Q3, representing 33% YoY growth Reduced Q3 Net Loss by 38% and Net Cash Used in Operations by 50% Launched iQ3 in Europe and opened new markets in Indonesia, the Netherlands, and Belgium Announced the formation of Octiv™, a wholly owned subsidiary focused on bringing Butterfly's chip to new sectors Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for th

Training product provides healthcare practitioners, medical schools, and health systems with a simple, effective, and accessible program for mastering cardiac ultrasounds. HeartFocus, the revolutionary, AI-enabled heart echo software by data-driven medtech company, DESKi, is proud to announce the launch of the HeartFocus Education app in partnership with Butterfly Network, Inc., ("Butterfly") (NYSE:BFLY) a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241028837462/en/HeartFocus unveils NEW AI-powered Educati

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on November 1 to discuss third quarter 2024 financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

KCU incorporates Butterfly Network's AI-guided ScanLab™ education application into its curriculum to empower dedicated, hands-on ultrasound training. KANSAS CITY, Mo. and BURLINGTON, Mass., Oct. 8, 2024 /PRNewswire/ -- Kansas City University (KCU) is revolutionizing medical education by becoming a leader in point-of-care ultrasound (POCUS) training. In collaboration with Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), KCU transformed its POCUS training curriculum by debuting a first-of-its-kind, hands-on POCUS elective in its 2024 curriculum. This innovative program makes KCU the first U.S. medical school to leverage Butterfly ScanLab™ as the foundation of its POCUS curriculum. The appr

URMC increased ultrasound charge capture by 116% following system-wide deployment of Butterfly Network devices and Compass™ workflow software. URMC's implementation results published on September 16, 2024 in the Journal of Clinical Imaging Science. Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today published a case study highlighting the positive impact of University of Rochester Medical Center's (URMC) transformative, system-wide deployment of Butterfly's point-of-care ultrasound (POCUS) devices and enterprise ultrasound platf

Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Fierce Life Sciences and Fierce Healthcare have named Butterfly as one of 2024's Fierce 50 honorees. The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909393991/en/Butterfly Network named a 2024 Fierce 50 Honoree. (Graphic: Business Wire) Butterfly's inclusion in

September 12, 2024 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference, taking place in New York City on September 12, 2024. Heather Getz, Chief Financial and Operations Officer at Butterfly Network, will represent Butterfly in one-on-one investor meetings at the conference. For more information or to schedule a meeting with Heather Getz at the conference, please contact your Lake Street representative. About Butterfly Network Founded by Dr. Jonathan Rothberg in 2011, Butterf

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

3 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

Delivered Quarterly Revenue of $20.6mm, 33% YoY Growth Raises Full Year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $20.6 million in Q3, representing 33% YoY growth Reduced Q3 Net Loss by 38% and Net Cash Used in Operations by 50% Launched iQ3 in Europe and opened new markets in Indonesia, the Netherlands, and Belgium Announced the formation of Octiv™, a wholly owned subsidiary focused on bringing Butterfly's chip to new sectors Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for th

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on November 1 to discuss third quarter 2024 financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

Reports Record Quarterly Revenue Raises Full Year Adjusted EBITDA Guidance Delivered record quarterly Revenue of $21.5 million in Q2, representing 16% YoY growth Reduced Q2 Net Loss by 45% and Net Cash Used in Operations by 62% Successfully launched medical school Campus Essentials program Launched iQ3 in Canada and expanded into new markets in Southeast Asia Filed for revocation of the RoHS handheld piezoelectric crystal ultrasound exemptions Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for t

07/18/2024 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2024 financial results on August 1, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET on August 1, 2024, to discuss second quarter 2024 financial results and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on But

Achieves 14% Revenue Growth - Exceeding Expectations Raises Full Year Guidance Delivered record first quarter Revenue of $17.7 million Reduced Net Loss by 35% and Net Cash Used in Operations by 52% Successfully launched next generation device Butterfly iQ3™ and training app ScanLab™ Received European Union Medical Device Regulation (EU MDR) certification Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. Joseph DeVivo, Butterfly's Chairman and CEO

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET on May 1, 2024, to discuss first quarter 2024 financial results and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.

Completed Cost Savings and New Initiatives Position Butterfly for Growth Delivered $65.9 million of Revenue – better than expectations Launched next generation device iQ3 and ScanLab in 2024 Completed the removal of over $170 million in costs from the business Reduced annual cash burn to approximately $60 million Announced upcoming Investor Day on March 18, 2024, at the New York Stock Exchange Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), an innovative digital health company transforming care through a unique combination of portable, semiconductor-based ultrasound technology, intuitive software, services and educational offerings that can make medical

Company to Hold Investor Day on March 18, 2024, at the New York Stock Exchange Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will report fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET, February 28, 2024, to discuss the financial results and operational progress. The conference call will be broadcast l

Delivers on Multiple Growth Initiatives Announced 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Launched Butterfly Garden, an Artificial Intelligence Marketplace with New Applications for Butterfly Users Introduced Two Ultrasound Education Offerings at ACEP23 to Boost Awareness and Adoption Completed Previously Announced Costs Reductions While Investing in Growth Submitted iQ3 for FDA approval Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the quarter ended S

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2023 financial results and provide a business update on November 2, 2023, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice-President, and Chief Financial and Operations Officer, will host a conference call and webcast at 4:30 pm ET on November 2, 2023, to discuss third quarter 2023 financial results and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relat

10-Q - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

144 - Butterfly Network, Inc. (0001804176) (Subject)

10-Q - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

S-8 - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

144 - Butterfly Network, Inc. (0001804176) (Subject)

144 - Butterfly Network, Inc. (0001804176) (Subject)

10-Q - Butterfly Network, Inc. (0001804176) (Filer)

Lake Street initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $2.25

Oppenheimer initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $4.50

B. Riley Securities initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $9.50

UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $7.00

Cowen initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $20.00

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G - Butterfly Network, Inc. (0001804176) (Subject)

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f

SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras as their Vice President of Marketing. A visionary marketing leader with extensive experience in medtech, Miras brings a wealth of expertise in creating memorable healthcare brands that accelerate commercial growth. "I am honored to join Avive's leadership team at such a transformative time for

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin

Health Tech Executive Brings More Than 35 Years of Business Experience and Operational Excellence to Butterfly Butterfly Network, Inc., a digital health company transforming care through the power of handheld, whole-body ultrasound, has announced the appointment of Joseph M. DeVivo as its new President and Chief Executive Officer (CEO), effective immediately. Mr. DeVivo will also join Butterfly's Board of Directors, serving as Chairman. DeVivo brings over 35 years of business leadership experience, having held leadership positions at healthcare and medical device companies, as well as non-profit organizations. Prior to joining Butterfly, DeVivo served as President of Hospitals and Healt

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" the "Company"), a digital health company transforming care with handheld, whole-body ultrasound, announced that the Company and Todd Fruchterman, M.D., Ph.D. have mutually agreed that Dr. Fruchterman will leave his position as President and Chief Executive Officer and as a member of the Board of Directors. Dr. Fruchterman will partner with Butterfly's leadership team through the end of the year to ensure a smooth transition. "On behalf of the Board I want to thank Todd for his vision, passion and dedication to Butterfly during his tenure," said Jonathan Rothberg, Founder and Chairman of the Board. "Todd has built a highly capable leadership

Company Announces Hiring of Tamara Dillon as Chief People Officer and Larry Weiss as Chief Legal Officer and Corporate Secretary Both Executives Bring Healthcare, Public Company, and Growth Experience to their Respective Roles Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Tamara Dillon to the position of Chief People Officer (CPO), effective May 31, and Larry Weiss to the position of Chief Legal Officer and Corporate Secretary, effective May 23. "The addition of Tamara and Larry brings two extraordinary leaders with great depth of experience working within public companies, scaling

Former Google Health Executive to Expand Cardiovascular Strategy for Ocular Health Technology Company Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract's Head of Cardiovascular and Digital Health. This key role completes Tesseract's leadership team and coincides with a series of critical, strategic hires under the helm of CEO Vicky Demas, PhD. Dr. McConnell was brought on to leverage Tesseract's technology to guide the expansion of its cardiovascular strategy. In this role, he is poised to lead and champion the design, planni

Health Tech Executive Brings 25 years of Financial and Operational Experience to Butterfly Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Heather Getz to the position of Executive Vice President and Chief Financial Officer, effective May 2. "Heather brings a compelling blend of healthcare technology and public company experience along with a successful track record in operational and financial discipline that is well suited to support and enhance Butterfly's continued growth and evolution," ​said Dr. Todd Fruchterman, Butterfly's President and Chief Executive Officer. "As a proven CFO

Dr. Erica Schwartz joins Butterfly's Board of Directors Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced the expansion of its Board of Directors to nine directors through the appointment of Dr. Erica Schwartz and the addition of Troy Quander to the leadership team as Senior Vice President, Regulatory and Quality. These appointments continue to strengthen the technical foundation of the company to ensure that it can effectively execute its mission of dem

Dr. Andrei Stoica and David Ramsey will lead the effort to strengthen innovation and technology infrastructure as Chief Technology Officer and Chief Information Officer, respectively.   Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and enable global health equity, today announced that effective July 19, Dr. Andrei Stoica will be joining Butterfly as Chief Technology Officer (CTO), and David Ramsey will be joining as Chief Information Officer (CIO). In this newly created executive position, Dr. Stoica will lead Butterfly's product development, technology innovation, and information technology operation

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology.The bundled bladder solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly.Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today introduced its first specialty product, iQ+ Bladder™, now available for purchase in the United States. The bundled solution includes an iQ+ Bladder

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSolutions (NYSE:EBS) shares moved upwards by 52.84% to $2.95. The market value of their outstanding shares is at $154.5 million. As per the press release, Q1 earnings came out yesterday. Aptevo Therapeutics (NASDAQ:APVO) stock rose 35.41% to $1.3. The company's market cap stands at $4.6 million. Context Therapeutics (NASDAQ:CNTX) stock rose 34.55% to $1.83. The company's market cap stands at $29.2 million. Skye Bioscience (NASDAQ:SKYE) stock increased by 25.09% to $16.0. The company's market

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Aspen Aerogels posted a GAAP loss of 2 cents per share, compared to market expectations for a loss of 11 cents per share. The company's quarterly sales came in at $94.501 million versus estimates of $75.004 million, according to data from Benzinga Pro. Aspen Aerogels shares jumped 26.2% to $19.21 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Emergent BioSolutions Inc. (NYSE:EBS) gained 72.1% to $3.32 in pre-market trading after the company announced operational changes t

The company sees Adjusted EBITDA loss of $55 million - $50 million versus prior view of Adjusted EBITDA loss of $60 million - $50 million.

Gainers Pulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday's after-market session. The market value of their outstanding shares is at $388.1 million. The company's, Q1 earnings came out today. Butterfly Network (NYSE:BFLY) shares moved upwards by 18.15% to $0.93. The company's market cap stands at $193.5 million. As per the press release, Q1 earnings came out today. Compass Therapeutics (NASDAQ:CMPX) stock rose 11.46% to $1.75. The market value of their outstanding shares is at $240.7 million. Sharps Technology (NASDAQ:STSS) shares increased by 9.2% to $0.27. The market value of their outstanding shares is at $4.2 million. Blueprint Medicines (NASDAQ:BPMC) shares moved up

Butterfly Network (NYSE:BFLY) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 36.36 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $17.656 million which beat the analyst consensus estimate of $16.800 million by 5.10 percent. This is a 14.09 percent increase over sales of $15.476 million the same period last year.

Shares of Butterfly Network, Inc. (NASDAQ:BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million. Butterfly Network shares dipped 21.7% to $1.1588 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Enveric Biosciences, Inc. (NASDAQ:ENVB) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to purs